Answers are grounded in this paper and cite their sources.
Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality and transarterial chemoembolisation (TACE) is an established technique to treat patients with intermediate-stage HCC. The aim of this study was to generate accurate costing data on cTACE and DEB-TACE in an Australian setting and assess whether one of the procedures offers favourable cost-effectiveness.
No takes yet. Share an insight, caveat, or question.
Clements et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: